Question follow-through · 107110
Blood Cancer: Medical Treatments
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the severity modifier on recent NICE recommendations on blood cancer treatments.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 20 Jan 2026
- Target answer date
- 26 Jan 2026
- Answer
- 26 Jan 2026 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Medicine: Training · 27 Jan 2026
- Medicine: Graduates · 27 Jan 2026
- Medicine: Graduates · 27 Jan 2026
- Medicine: Graduates · 27 Jan 2026
- Doctors: Training · 27 Jan 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
20 Jan 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the severity modifier on recent NICE recommendations on blood cancer treatments.
26 Jan 2026
Target answer date
Date supplied by the official written-questions record.
26 Jan 2026
Answer published
Since the introduction of the severity modifier, the National Institute for Health and Care Excellence has approved 27 out of 28 blood cancer medicines it evaluated, reflecting an approval rate of 96%. Of these topics, a severity weighting was applied in ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Medicine: Training
27 Jan 2026 · To ask the Secretary of State for Health and Social Care, how many additional medical places are funded in start in 2026 compared with 2025.
Medicine: Graduates
27 Jan 2026 · To ask the Secretary of State for Health and Social Care, what number of UK citizens have obtained a primary medical degree outside the UK by country in each of the last five years.
Medicine: Graduates
27 Jan 2026 · To ask the Secretary of State for Health and Social Care, how many and what proportion of UK primary medical degree graduates were (a) British and (b) non-British by country in each of the last five years.
Medicine: Graduates
27 Jan 2026 · To ask the Secretary of State for Health and Social Care, how many and what proportion of (a) home students and (b) non-home students who graduated from the UK with a primary medical degree from 2010 to 2020 remain working in the NHS.
Doctors: Training
27 Jan 2026 · To ask the Secretary of State for Health and Social Care, how many staff responsible for UK Foundation programme allocation process are (a) NHS employees, (b) civil servants and (c) people involved in direct clinical care.
Surgical Mesh Implants and Sodium Valproate: Compensation
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, how many full time equivalent civil servants are working on his Department's response to the Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 Februar
Puberty Suppressing Hormones: Clinical Trials
23 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to the Written Statement of 23 February 2026 on Clinical Trials, what information his Department holds on when the letter from MHRA to King's College London was (a) sent and (b) rece
Puberty Suppressing Hormones: Clinical Trials
23 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to the Written Statement of 23 February 2026 on Clinical trials, whether (a) he, (b) Ministers and (c) officials had discussions with MHRA on the Pathways clinical trial prior to Feb
Puberty Suppressing Hormones: Clinical Trials
23 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether all arms of the Pathways clinical trials have been paused.
Puberty Suppressing Hormones: Clinical Trials
23 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether any children were recruited for any arm of the Pathways clinical trials prior to it being paused.
NHS: Databases
23 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether (a) he, (b) Ministers and (c) officials had discussions with (i) NHS England, (ii) University of York and (iii) other researchers on the Data Linkage study in (A) November 2025, (B) Decembe
Prostate Cancer: Screening
24 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether he has reviewed the findings of the independent analysis commissioned by Prostate Cancer Research on the economic model used by the UK National Screening Committee.